Trials / Recruiting
RecruitingNCT07083206
A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe
A Multi-center, Prospective, Non-intervention, Observational Study to Evaluate the Effectiveness and Safety of Switching to Pevarozet Tablet in Patients With Hypercholesterolemia Previously Treated With Atorvastatin or Rosuvastatin Monotherapy
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,500 (estimated)
- Sponsor
- Ahn-Gook Pharmaceuticals Co.,Ltd · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the effectiveness and safety of Pitavastatin/Ezetimibe FDC in patients with hypercholesterolemia.
Conditions
Timeline
- Start date
- 2025-07-29
- Primary completion
- 2028-07-01
- Completion
- 2029-01-01
- First posted
- 2025-07-24
- Last updated
- 2025-08-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07083206. Inclusion in this directory is not an endorsement.